CORDIS bietet Links zu öffentlichen Ergebnissen und Veröffentlichungen von HORIZONT-Projekten.
Links zu Ergebnissen und Veröffentlichungen von RP7-Projekten sowie Links zu einigen Typen spezifischer Ergebnisse wie Datensätzen und Software werden dynamisch von OpenAIRE abgerufen.
Leistungen
This report describes current policies at the European and if useful national levels that guide or determine the development of new drugs against COVID19
Report on collaborations and impact assessment (öffnet in neuem Fenster)This reports describes the first activities with other research and innovation initiatives and established contacts as well as an impact assessment of these An updated version will be submitted at the end of the projectA brief report on the main outcomes of the meeting with the European COVID19 clinical trial network for therapeutics covid19trialseu and possible followup actions will be considered Upon availability of clinical trial data that would allow further evaluation in Phase II clinical trials of the developed therapeutic compounds the coordinator will contact the European COVID19 clinical trial network for therapeutics covid19trialseuecrinorg to explore the compounds suitability for the European network of largescale multicentre clinical trials for hospitalized patients covid19trialseu
"Report on virtual meeting with the other successful projects working on COVID-19 therapeutics funded under the Horizon Europe call ""HORIZON-HLTH-2021-CORONA-01" (öffnet in neuem Fenster)A virtual meeting will be set up by DG RTD in coordination with HaDEA between the projects working on COVID19 therapeutics funded under the Horizon Europe call HORIZONHLTH2021CORONA01 at the beginning of the projects lifetime This meeting is to introduce each project to each other and to identify areas for potential collaboration The brief report submitted shall include the minutes of the meeting and a plan on how to move forward in identified possible areas of collaboration Participation of the coordinators of the European COVID19 clinical trial network for therapeutics covid19trialseu will be considered for this meeting to introduce the relevant adaptive platform trials
Analysis of barriers for uptake (öffnet in neuem Fenster)This report describes possible barriers related to the future update of the FX06based therapy by clinical staff and other stakeholder groups
Interim impact report (öffnet in neuem Fenster)This report describes the results of an assessment of the communication and dissemination measures impact
Governance Report (öffnet in neuem Fenster)This report describes the organisational structure of the project management the roles and responbilities of the consortium bodies as defined in the Consortium Agreement
Training material (öffnet in neuem Fenster)This report describes the types structure and content of training material to be used for the training of clinical staff before and during the implementation of the clinical study
"Progress report on the collaborative actions between the projects working on COVID-19 therapeutics funded under the Horizon Europe call ""HORIZON-HLTH-2021-CORONA-01""" (öffnet in neuem Fenster)The brief report will provide an update on the collaborative efforts that were undertaken in the first 18 months of the pro-jects’ duration, also according to what was laid in D1.7.
Plan for dissemination including communication activities (öffnet in neuem Fenster)This report describes the aims the strategy and the planned measures related to the communication and dissemination of the project and its results
The project website documentation covers technical aspects the first website structure and initial content
Veröffentlichungen
Autoren:
Kloka, Jan; Friedrichson, Benjamin; Dauth, Stephanie; Foldenauer, Ann Christina; Bulczak-Schadendorf, Anita; Vehreschild, Maria J. G. T.; Matos, Francisco Maio; Riera-Mestre, Antoni; van Asselt, Antoinette D. I.; De Robertis, Edoardo; Juskeviciene, Vilma Traskaite; Meybohm, Patrick; Tomescu, Dana; Lacombe, Karine; Stehouwer, Coen D. A.; Zacharowski, Kai
Veröffentlicht in:
2022, ISSN 0967-0912
Herausgeber:
Institute of Materials
DOI:
10.6084/m9.figshare.20521689
Autoren:
Jan Andreas Kloka; Benjamin Friedrichson; Petra Wülfroth; Rainer Henning; Kai Zacharowski
Veröffentlicht in:
Cells, Vol 12, Iss 10, p 1345 (2023), 2023, ISSN 2073-4409
Herausgeber:
MDPI
DOI:
10.3390/cells12101345
Autoren:
Clazinus Veijer; Marinus H. van Hulst; Benjamin Friedrichson; Maarten J. Postma; Antoinette D.I. van Asselt
Veröffentlicht in:
PharmacoEconomics, 2024, ISSN 1170-7690
Herausgeber:
Adis International Ltd
DOI:
10.1007/S40273-024-01375-X
Autoren:
Värri, A. O., Kallonen, A., Asuroglu, T., & van Gils, M.
Veröffentlicht in:
Finnish Journal of eHealth and eWelfare, 2023, ISSN 1798-0798
Herausgeber:
Finnish Social and Health Informatics Association
DOI:
10.23996/fjhw.126881
Autoren:
Kloka, Jan; Friedrichson, Benjamin; Dauth, Stephanie; Foldenauer, Ann Christina; Bulczak Schadendorf, Anita; Vehreschild, Maria J. G. T.; Matos, Francisco Maio; Riera Mestre, Antoni; Van Asselt, Antoinette D. I.; De Robertis, Edoardo; Juskeviciene, Vilma
Veröffentlicht in:
Trials, 23(1):688. BioMed Central Ltd, 2022, ISSN 1745-6215
Herausgeber:
Trials
DOI:
10.1186/s13063-022-06609-x
Suche nach OpenAIRE-Daten ...
Bei der Suche nach OpenAIRE-Daten ist ein Fehler aufgetreten
Es liegen keine Ergebnisse vor